Free Trial

Siemens Fonds Invest GmbH Sells 18,220 Shares of Danaher Co. (NYSE:DHR)

Danaher logo with Medical background

Siemens Fonds Invest GmbH cut its position in Danaher Co. (NYSE:DHR - Free Report) by 78.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,074 shares of the conglomerate's stock after selling 18,220 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Danaher were worth $1,165,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at $27,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher during the 4th quarter valued at $31,000. Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 57 shares during the period. Finally, Kentucky Trust Co bought a new stake in shares of Danaher during the 4th quarter valued at $34,000. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DHR has been the subject of a number of recent analyst reports. Barclays upped their target price on Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. dropped their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Citigroup restated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. The Goldman Sachs Group dropped their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Finally, Wall Street Zen downgraded Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $263.24.

View Our Latest Report on DHR

Insiders Place Their Bets

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.20% of the company's stock.

Danaher Trading Down 0.5%

Shares of DHR stock traded down $0.93 on Friday, hitting $189.54. The company had a trading volume of 6,514,078 shares, compared to its average volume of 3,485,177. The firm has a market cap of $135.65 billion, a P/E ratio of 35.90, a P/E/G ratio of 2.66 and a beta of 0.80. The stock's 50-day moving average is $192.72 and its two-hundred day moving average is $213.78. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. On average, equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's dividend payout ratio is currently 24.85%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines